Suchergebnisse - "Tian, Hongqi"

PubPharm (87)

1

A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Wei, X. | Zou, Z. | Zhang, W. | +21

2

PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUNDS AS KRAS INHIBITOR

enthalten in: Europäisches Patentamt | 2024

von TIAN HONGQI | HUANG GONGCHAO | GAO XUGUANG | +2

3

HETEROCYCLIC COMPOUNDS AS KRAS INHIBITORS, AND PREPARATION AND THERAPEUTIC USE THEREOF

enthalten in: Europäisches Patentamt | 2024

von TIAN HONGQI | HUANG GONGCHAO | GAO XUGUANG | +1

4

Use of aminothiol compounds as cerebral nerve or heart protective agent

enthalten in: Europäisches Patentamt | 2024

von TIAN HONGQI | LIU YAHONG

5

Use of aminothiol compounds as cerebral nerve or heart protective agent

enthalten in: Europäisches Patentamt | 2024

von TIAN HONGQI | LIU YAHONG

6

AMINO MERCAPTAN COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF IN PROTECTION AGAINST RADIATION

enthalten in: Europäisches Patentamt | 2023

von TIAN HONGQI | CHENG YING | ZHANG QIANRU | +2

7

KZ02 enhances the radiosensitivity of BRAF-mutated CRC in vitro and in vivo

enthalten in: European journal of pharmacology | 2023

von Guo, Y. | Li, X. | Yuan, R. | +4

8

Compound 5 alleviated acute kidney injury without affecting the antitumor effect after cisplatin treatment

enthalten in: Biochemical and biophysical research communications | 2023

von Guo, Y. | Li, X. | Yuan, R. | +3

9

PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUND AS KRAS INHIBITOR

enthalten in: Europäisches Patentamt | 2023

von TIAN HONGQI | HUANG GONGCHAO | GAO XUGUANG | +2

10

PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUND AS KRAS INHIBITOR

enthalten in: Europäisches Patentamt | 2023

von TIAN HONGQI | HUANG GONGCHAO | GAO XUGUANG | +2

1
2
3
4
5
6
7
8
9
Nächster »
[9]